5,925
Views
0
CrossRef citations to date
0
Altmetric
Dermatology

Recognizing skin conditions in patients with cirrhosis: a narrative review

, , , , ORCID Icon, , & ORCID Icon show all
Pages 3016-3028 | Received 11 May 2022, Accepted 18 Oct 2022, Published online: 29 Oct 2022

References

  • Hazin R, Abu-Rajab Tamimi TI, Abuzetun JY, et al. Recognizing and treating cutaneous signs of liver disease. Cleve Clin J Med. 2009;76(10):599–606.
  • Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171.
  • Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77.
  • Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817.
  • Beste LA, Leipertz SL, Green PK, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology. 2015;149(6):1471–1482.
  • Zou B, Yeo YH, Jeong D, et al. A nationwide study of inpatient admissions, mortality, and costs for patients with cirrhosis from 2005 to 2015 in the USA. Dig Dis Sci. 2020;65(5):1520–1528.
  • Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38(4):570–580.
  • Okumura H, Aramaki T, Katsuta Y, et al. Regional differences in peripheral circulation between upper and lower extremity in patients with cirrhosis. Scand J Gastroenterol. 1990;25(9):883–889.
  • Steele JD, Dillon JF, Plevris JN, et al. Hand skin temperature changes in patients with chronic liver disease. J Hepatol. 1994;21(6):927–933.
  • Serrao R, Zirwas M, English JC. Palmar erythema. Am J Clin Dermatol. 2007;8(6):347–356.
  • Amoroso S, Pastore S, Tommasini A, et al. Palmar erythema: a diagnostic clue of juvenile dermatomyositis. J Paediatr Child Health. 2020;56(7):1159.
  • Li CP, Lee FY, Hwang SJ, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol. 1999;94(2):502–507.
  • Li CP, Lee FY, Hwang SJ, et al. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol. 1999;34(5):520–523.
  • Silvério AdO, Guimarães DC, Elias LFQ, et al. Are the spider angiomas skin markers of hepatopulmonary syndrome? Arq Gastroenterol. 2013;50(3):175–179.
  • Ghosn SH, Kibbi AG. Cutaneous manifestations of liver diseases. Clin Dermatol. 2008;26(3):274–282.
  • Yigider AP, Kayhan FT, Yigit O, et al. Skin diseases of the nose. Am J Rhinol Allergy. 2016;30(3):83–90.
  • Li CP, Lee FY, Hwang SJ, et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol. 2003;9(12):2832–2835.
  • Gu JW, Elam J, Sartin A, et al. Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis. Am J Physiol Regul Integr Comp Physiol. 2001;281(1):R365–R372.
  • Lee HW, Yun WJ, Choi JC, et al. Arteriovenous haemangioma in chronic liver diseases: case report and determination of oestrogen receptor status. J Eur Acad Dermatol Venereol. 2006;20(7):884–885.
  • Akiyama M, Inamoto N. Arteriovenous haemangioma in chronic liver disease: clinical and histopathological features of four cases. Br J Dermatol. 2001;144(3):604–609.
  • Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000;43(1):1–16.
  • Li T, Zhi XT, Hu SY. Congenital portal venous system aneurysms associated with caput medusae. Hepatology. 2011;53(3):1052–1053.
  • Qi X, Han G. Images in clinical medicine. Abdominal-wall varices in the Budd-Chiari syndrome. N Engl J Med. 2014;370(19):1829.
  • Philips CA, Arora A, Shetty R, et al. A comprehensive review of portosystemic collaterals in cirrhosis: historical aspects, anatomy, and classifications. Int J Hepatol. 2016;2016:6170243.
  • Chen PT, Tzeng HL, Wang HP, et al. Caput medusae bleeding. Am J Gastroenterol. 2020;115(10):1570.
  • Sze DY, Magsamen KE, McClenathan JH, et al. Portal hypertensive hemorrhage from a left gastroepiploic vein caput medusa in an adhesed umbilical hernia. J Vasc Interv Radiol. 2005;16(2):281–285.
  • Strauss C, Sivakkolunthu M, Ayantunde AA. Recurrent and troublesome variceal bleeding from parastomal caput medusae. Korean J Gastroenterol. 2014;64(5):290–293.
  • Salem A, Gamil H, Hamed M, et al. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010;24(6):649–654.
  • Terry R. White nails in hepatic cirrhosis. Lancet. 1954;266(6815):757–759.
  • Nia AM, Ederer S, Dahlem KM, et al. Terry’s nails: a window to systemic diseases. Am J Med. 2011;124(7):602–604.
  • Li Z, Ji F, Deng H. Terry’s nails. Braz J Infect Dis. 2012;16(3):311–312.
  • Nelson N, Hayfron K, Diaz A, et al. Terry’s nails: clinical correlations in adult outpatients. J Gen Intern Med. 2018;33(7):1018–1019.
  • Holzberg M, Walker HK. Terry’s nails: revised definition and new correlations. Lancet. 1984;1(8382):896–899.
  • Coskun BK, Saral Y, Ozturk P, et al. Reiter syndrome accompanied by terry nail. J Eur Acad Dermatol Venereol. 2005;19(1):87–89.
  • Pitukweerakul S, Pilla S. Terry’s nails and Lindsay’s nails: two nail abnormalities in chronic systemic diseases. J Gen Intern Med. 2016;31(8):970.
  • Sharma V, Kumar V. Muehrcke lines. Canadian Med Assoc J. 2013;185(5):E239.
  • Kozaru T, Fukumoto T, Shirai T, et al. Muehrcke lines on fingers and toenails. Eur J Dermatol. 2019;29(1):87–88.
  • Fawcett RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic disease. Am Fam Physician. 2004;69:1417–1424.
  • Chen W, Yu YS, Liu YH, et al. Nail changes associated with chemotherapy in children. J Eur Acad Dermatol Venereol. 2007;21(2):186–190.
  • Chang X, Zhen P, Zeng J. Fingernails changes associated with chemotherapy in breast cancer: Muehrcke’s lines. Clin Case Rep. 2018;6(8):1653–1654.
  • Ates D, Kosemehmetoglu K. Acquired leukonychia of the distal nail plate: a morphologic and proteomic analysis. Am J Dermatopathol. 2020;42(4):261–264.
  • Wilkerson MG, Wilkin JK. Red lunulae revisited: a clinical and histopathologic examination. J Am Acad Dermatol. 1989;20(3):453–457.
  • Dzieżyc-Jaworska K, Litwin T, Członkowska A. Clinical manifestations of Wilson disease in organs other than the liver and brain. Ann Transl Med. 2019;7(2):S62.
  • Gregoriou S, Argyriou G, Larios G, et al. Nail disorders and systemic disease: what the nails tell us. J Fam Pract. 2008;57(8):509–514.
  • Spicknall KE, Zirwas MJ, English JC. 3rd. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005;52(6):1020–1028.
  • Callemeyn J, Van Haecke P, Peetermans WE, et al. Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance. Acta Clin Belg. 2016;71(3):123–130.
  • Zaias N, Escovar SX, Zaiac MN. Finger and toenail onycholysis. J Eur Acad Dermatol Venereol. 2015;29(5):848–853.
  • Gandhi V, Nagral A, Philip S, et al. Reversal of nail changes after liver transplantation in a child. Indian J Gastroenterol. 2009;28(4):154–156.
  • Chessa MA, Iorizzo M, Richert B, et al. Pathogenesis, clinical signs and treatment recommendations in brittle nails: a review. Dermatol Ther. 2020;10(1):15–27.
  • van de Kerkhof PC, Pasch MC, Scher RK, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005;53(4):644–651.
  • Solak B, Acikgoz SB, Sipahi S, et al. Cutaneuos findings in patients with predialysis chronic kidney disease. J Eur Acad Dermatol Venereol. 2016;30(9):1609–1613.
  • Walker J, Baran R, Vélez N, et al. Koilonychia: an update on pathophysiology, differential diagnosis and clinical relevance. J Eur Acad Dermatol Venereol. 2016;30(11):1985–1991.
  • Chinazzo M, Lorette G, Baran R, et al. Nail features in healthy term newborns: a single-Centre observational study of 52 cases. J Eur Acad Dermatol Venereol. 2017;31(2):371–375.
  • Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525–539.
  • Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835–851.
  • Koulentaki M, Ioannidou D, Stefanidou M, et al. Dermatological manifestations in primary biliary cirrhosis patients: a case control study. Am J Gastroenterol. 2006;101(3):541–546.
  • Michalopoulos NV, Keshtgar MR. Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment. N Engl J Med. 2012;367(15):1449.
  • Neong SF, Billington EO, Congly SE. Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: review of pathogenesis and management. Hepatology. 2019;69(6):2683–2695.
  • Sehgal R, Singh H, Singh IP. Comparative study of spironolactone and eplerenone in management of ascites in patients of cirrhosis of liver. Eur J Gastroenterol Hepatol. 2020;32(4):535–539.
  • Glantz A, Reilly SJ, Benthin L, et al. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology. 2008;47(2):544–551.
  • Oeda S, Takahashi H, Yoshida H, et al. Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res. 2018;48(3):E252–E262.
  • Montagnese S, Nsemi LM, Cazzagon N, et al. Sleep-wake profiles in patients with primary biliary cirrhosis. Liver Int. 2013;33(2):203–209.
  • Bergasa NV, Alling DW, Talbot T, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med. 1995;123(3):161–167.
  • Talwalkar JA, Souto E, Jorgensen RA, et al. Natural history of pruritus in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2003;1(4):297–302.
  • Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, et al. Assessment of health related quality of life in polish patients with primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2016;40(4):471–479.
  • Shah RA, Kowdley KV. Mechanisms and treatments of pruritus in primary biliary cholangitis. Semin Liver Dis. 2019;39(2):209–220.
  • Carrion AF, Rosen JD, Levy C. Understanding and treating pruritus in primary biliary cholangitis. Clin Liver Dis. 2018;22(3):517–532.
  • Zak A, Zeman M, Slaby A, et al. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(2):181–188.
  • Schmidt HH, Manns MP. Images in hepatology. Regression of xanthelasmas in a patient with primary biliary cirrhosis after liver transplantation. J Hepatol. 1998;28(6):1077.
  • Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol. 2011;1(3):177–184.
  • Rugivarodom M, Charatcharoenwitthaya P. Nontumoral portal vein thrombosis: a challenging consequence of liver cirrhosis. J Clin Transl Hepatol. 2020;28(8):432–444.
  • Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–156.
  • Mammen EF. Coagulation defects in liver disease. Med Clin North Am. 1994;78(3):545–554.